Universe PharmaceuticalsUPC +6.86%58 PB Ratio is 0.03 as of Jun. 29, 2026, which is 89% below its 10-year median of 0.27. GuruFocus rates UPC with a GF Score™ of 58/100 and a GF Value™ of $5.22 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 922 Drug Manufacturers companies, Universe Pharmaceuticals ranks better than 99.89% on this metric.
The historical rank and industry rank for Universe Pharmaceuticals's PB Ratio or its related term are showing as below:
UPC'
s PB Ratio Range Over the Past 10 Years
Min: 0.01 Med: 0.27 Max: 5.45
Current: 0.03
During the past 8 years, Universe Pharmaceuticals's highest PB Ratio was 5.45. The lowest was 0.01. And the median was 0.27.
UPC's PB Ratio is ranked better than 99.89% of 922
companies
in the Drug Manufacturers industry
Industry Median: 1.845
vs UPC: 0.03
During the past 12 months, Universe Pharmaceuticals's average Book Value Per Share Growth Rate was -91.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -76.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -50.50% per year.
During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of Universe Pharmaceuticals was 82.60% per year. The lowest was -76.60% per year. And the median was 10.40% per year.
Back to Basics: PB Ratio
Universe Pharmaceuticals (NAS:UPC) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Universe Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Universe Pharmaceuticals PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Universe Pharmaceuticals's PB Ratio distribution charts can be found below:
* The bar in red indicates where Universe Pharmaceuticals's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Universe Pharmaceuticals (UPC) has a PB Ratio of 0.03 as of Jun. 29, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Universe Pharmaceuticals and its competitors. This is 89% below median its historical median of 0.27. Over the past decade, Universe Pharmaceuticals' PB Ratio has ranged from 0.01 to 5.45. According to the industry distribution chart, Universe Pharmaceuticals ranks #1 out of 922 companies in the Drug Manufacturers industry, placing it in the top 0.099999999999994%.
Is Universe Pharmaceuticals' PB Ratio too high?
Universe Pharmaceuticals' current PB Ratio of 0.03 is 89% below median its 10-year median of 0.27. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 5.45. The Drug Manufacturers industry median PB Ratio is 1.85. Universe Pharmaceuticals' value of 0.03 is 98.4% below this industry median. Based on the distribution chart, Universe Pharmaceuticals ranks #1 out of 922 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Universe Pharmaceuticals has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Universe Pharmaceuticals' PB Ratio compare to CPMD and SHPH?
According to the Drug Manufacturers industry distribution chart, Universe Pharmaceuticals ranks #1 out of 922 companies for PB Ratio. This places Universe Pharmaceuticals in the top 0% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.85. Universe Pharmaceuticals' value of 0.03 is 98.4% below this benchmark. Historically, Universe Pharmaceuticals' own PB Ratio has ranged from 0.01 to 5.45 over the past decade. While the company's 10-year median is 0.27 vs. the industry median of 1.85, Universe Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.85, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Universe Pharmaceuticals's current PB Ratio of 0.03 is 98.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Universe Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Universe Pharmaceuticals's current PB Ratio is 0.03, which is 89% below median its own 10-year median of 0.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universe Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Universe Pharmaceuticals (UPC) is currently considered Possible Value Trap. The stock's GF Value™ is $5.22, compared to a current price of $2.96 — trading 43.3% below its estimated fair value. The current PB Ratio is 0.03, which is 89% below median its 10-year median of 0.27 and 98.4% below the Drug Manufacturers industry median of 1.85. Universe Pharmaceuticals' overall GF Score™ is 58/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Universe Pharmaceuticals (UPC), the current PB Ratio is 0.03 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Universe Pharmaceuticals (UPC) Overvalued in 2026?
Based on GuruFocus' analysis, Universe Pharmaceuticals stock appears to be undervalued.
The current stock price of $2.96 is trading 43.3% below its estimated GF Value™ of $5.22.
GuruFocus considers Universe Pharmaceuticals to be Possible Value Trap.
Key valuation signals for UPC:
PB Ratio: 0.03 (89% below median its 10-year median of 0.27)
GF Value™: $5.22 vs. price of $2.96 (43.3% below fair value)
Industry Position: 98.4% below the Drug Manufacturers median (#1 of 922)
No single metric tells the full story. See the UPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
58GF Score
Get the complete analysis for UPC
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
UPC has been successfully added to your 
